The FDA has issued a warning regarding compounded drugs distributed by Fullerton Wellness, LLC, in Ontario, California.

Data from the SENZA-PDN trial showed 10 kHz SCS yielded long-term, clinically meaningful reductions in HbA1c and weight in patients with PDN and T2D.

Hormone replacement therapy (HRT) is associated with an increased risk for developing irritable bowel syndrome (IBS) in postmenopausal women.

HealthDay News — Doctors in New York City are chronicling the first known U.S. cases of sexually transmitted ringworm ( Trichophyton mentagrophytes ).

Heterozygous familial hypercholesterolemia was associated with increased type 2 diabetes risk, especially among those with obesity and statin use.

FSH levels were independently associated with an increased risk for hip fracture among older men and women regardless of bone density.

Topline results were announced from a phase 3 clinical trial evaluating subcutaneous semaglutide in obesity and knee osteoarthritis.

Sotagliflozin is an oral dual sodium-glucose co-transporter types 1 and 2 (SGLT1/SGLT2) inhibitor. The FDA panel voted against the approval of sotagliflozin for patients with type 1 diabetes and ...

Irregular sleep patterns, regardless of meeting recommended sleep durations, were associated with increased risk for type 2 diabetes.

Psychiatric comorbidity prevalence was modestly different between female patients with and without sex development disorders.

Surveillance programs for chronic hepatitis B, which also include a focus on treatment, can be beneficial for patients.

Hypertension is the most common cardiovascular disease (CVD) comorbidity seen among dialysis patients globally.